V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011893 | 240008085 | 1.73 | 58.7 | Palliative (P) | 2014-05-03 | 2014-05-20 | Bevacizumab | null | null | 240032871 | BEVACIZUMAB |
| 240011894 | 240008086 | 1.66 | 31.4 | Palliative (P) | 2014-07-13 | 2014-08-14 | Bevacizumab 15mg/kg | N | N | 240032888 | BEVACIZUMAB |
| 240011895 | 240008089 | 1.63 | 106 | Palliative (P) | 2013-08-28 | 2014-03-20 | Bevacizumab | N | N | 240032891 | BEVACIZUMAB |
| 240011896 | 240008090 | 1.85 | 97 | Disease modification (D) | null | 2017-12-18 | Trial Unspecified | null | null | 240032896 | TRIAL |
| 240011897 | 240008091 | null | null | Palliative (P) | null | 2017-06-15 | Bevacizumab 15mg/kg | null | null | 240032898 | BEVACIZUMAB |
| 240011898 | 240012332 | 1.53 | 74.4 | Adjuvant (A) | 2015-07-30 | 2015-09-17 | Carboplatin AUC 2 - 5 | N | N | 240032912 | CARBOPLATIN |
| 240011899 | 240008092 | null | 77.3 | Palliative (P) | 2019-03-27 | 2019-03-27 | Bevacizumab+Carbo+Pacliaxel | N | null | 240032915 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011900 | 240008094 | 1.61 | 61.3 | Palliative (P) | 2014-07-29 | 2014-08-03 | null | 02 | N | 240032920 | NOT MATCHED |
| 240011901 | 240008094 | null | 83.5 | Palliative (P) | 2016-10-21 | 2016-10-29 | Bevacizumab 15mg/kg | N | N | 240032920 | BEVACIZUMAB |
| 240011902 | 240008095 | null | 57.7 | Curative (C) | 2017-03-23 | 2017-04-14 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 240032923 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011903 | 240008096 | 1.74 | null | null | 2017-07-01 | 2017-07-08 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 240032933 | PACLITAXEL |
| 240011904 | 240008097 | 1.63 | 79.9 | Curative (C) | null | 2016-08-22 | CHOP | 02 | N | 240032934 | CHOP |
| 240011905 | 240008097 | 1.65 | 77.9 | Palliative (P) | 2013-08-14 | 2013-08-16 | PACLITAXEL | Y | null | 240032934 | PACLITAXEL |
| 240011906 | 240008098 | 1.64 | 89.8 | Curative (C) | 2013-07-06 | 2013-08-01 | Paclitaxel 7 day | 1 | N | 240032946 | PACLITAXEL |
| 240011907 | 240008100 | 1.56 | 75.11 | Palliative (P) | 2017-12-24 | 2017-12-24 | Paclitaxel 7 day | N | N | 240032953 | PACLITAXEL |
| 240011908 | 240008100 | 1.69 | null | Curative (C) | 2013-10-18 | 2013-10-20 | PACLITAXEL | N | N | 240032953 | PACLITAXEL |
| 240011909 | 240015856 | null | 74.8 | Palliative (P) | 2015-07-30 | 2015-08-04 | Bevacizumab+Carbo+Pacliaxel | 02 | null | 240032960 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011910 | 240015856 | 1.55 | 53 | Disease modification (D) | 2017-09-07 | 2017-09-07 | Methotrexate intrathecal | 01 | N | 240032960 | METHOTREXATE INTRATHECAL |
| 240011911 | 240016262 | null | 81.6 | Curative (C) | 2015-01-07 | 2015-01-07 | null | N | N | 240032993 | NOT MATCHED |
| 240011912 | 240008102 | 1.73 | 72.9 | Palliative (P) | 2016-03-04 | 2016-03-23 | Carboplatin AUC 2 - 5 | 02 | N | 240033004 | CARBOPLATIN |
| 240011913 | 240008103 | null | 63 | Palliative (P) | 2015-08-02 | 2015-08-03 | Paclitaxel 7 day | null | Y | 240033009 | PACLITAXEL |
| 240011914 | 240008103 | 1.75 | 36.8 | Palliative (P) | 2016-10-22 | 2016-11-03 | Trial Unspecified | 02 | N | 240033009 | TRIAL |
| 240011915 | 240008104 | null | 34.7 | null | 2016-07-10 | 2016-07-18 | Azacitidine | 02 | N | 240033012 | AZACITIDINE |
| 240011916 | 240012339 | null | 86 | Palliative (P) | null | 2017-09-28 | Trial Unspecified | N | null | 240033019 | TRIAL |
| 240011917 | 240008105 | null | 98.7 | Palliative (P) | 2015-03-22 | 2015-04-16 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | null | 240033048 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011918 | 240008108 | 1.62 | 56.5 | Palliative (P) | 2013-07-19 | 2013-08-22 | Azacitidine | 02 | N | 240033052 | AZACITIDINE |
| 240011919 | 240012342 | 1.67 | 107.5 | Disease modification (D) | 2019-05-29 | 2019-06-01 | Trial Unspecified | 02 | N | 240033057 | TRIAL |
| 240011920 | 240012342 | null | 50 | Palliative (P) | 2016-09-01 | 2016-09-04 | Bevacizumab | N | N | 240033057 | BEVACIZUMAB |
| 240011921 | 240008109 | 1.78 | null | Palliative (P) | 2014-06-19 | 2014-06-20 | Azacitidine | 2 | N | 240033064 | AZACITIDINE |
| 240011922 | 240008110 | 1.73 | 70.6 | Palliative (P) | 2015-05-10 | 2015-06-01 | Bevacizumab | 02 | N | 240033074 | BEVACIZUMAB |
| 240011923 | 240008110 | 1.58 | 65.6 | null | 2014-08-27 | 2014-08-31 | ALCL ALCL 99 Closed BM 1, 2 or 3 | 2 | N | 240033074 | NOT MATCHED |
| 240011924 | 240008111 | 1.65 | 45.2 | Disease modification (D) | 2013-06-25 | 2013-06-27 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240033085 | NOT MATCHED |
| 240011925 | 240008113 | 1.64 | 71 | Disease modification (D) | 2013-09-15 | 2013-09-23 | Methotrexate intrathecal | 02 | N | 240033086 | METHOTREXATE INTRATHECAL |
| 240011926 | 240008113 | 1.84 | 84 | Palliative (P) | null | 2017-02-26 | Bevacizumab+Carbo+Pacliaxel | null | null | 240033086 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011927 | 240012346 | 1.78 | 77.2 | Palliative (P) | 2014-12-17 | 2015-01-04 | Azacitidine | 2 | N | 240033090 | AZACITIDINE |
| 240011928 | 240008115 | 1.69 | null | Palliative (P) | 2015-10-12 | 2015-10-26 | Bevacizumab 15mg/kg | N | N | 240033096 | BEVACIZUMAB |
| 240011929 | 240008116 | null | 90.2 | Palliative (P) | 2016-04-14 | 2016-04-25 | Bevacizumab+Carbo+Pacliaxel | Y | N | 240033098 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011930 | 240012347 | 1.55 | 95 | null | 2014-02-22 | 2014-03-21 | VINCRISTINE + asparaginase spectrilla | 02 | N | 240033101 | NOT MATCHED |
| 240011931 | 240008118 | 1.54 | null | Palliative (P) | 2017-05-07 | 2017-05-09 | Trial Unspecified | null | null | 240033104 | TRIAL |
| 240011932 | 240008119 | null | 86.7 | Palliative (P) | 2017-06-23 | 2017-06-23 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 240033104 | PACLITAXEL |
| 240011933 | 240008120 | 1.45 | 37.4 | null | 2018-09-11 | 2018-09-25 | Bevacizumab | null | null | 240033117 | BEVACIZUMAB |
| 240011934 | 240008122 | 1.72 | null | Disease modification (D) | 2017-06-29 | 2017-07-02 | Methotrexate intrathecal | Y | N | 240033117 | METHOTREXATE INTRATHECAL |
| 240011939 | 240012352 | 1.57 | 93 | Curative (C) | null | 2018-08-27 | Methotrexate High Dose (3g/m2) | null | Y | 240033165 | GDP |
| 240011940 | 240012352 | 1.84 | 87.7 | Curative (C) | 2017-09-01 | 2017-09-21 | CARBOPLATIN + ETOPOSIDE | null | null | 240033165 | CARBOPLATIN + ETOPOSIDE |
| 240011941 | 240016263 | 1.62 | 56.1 | Palliative (P) | 2015-06-28 | 2015-07-03 | R Chlorambucil | N | N | 240033179 | CHLORAMBUCIL + RITUXIMAB |
| 240011942 | 240008125 | 1.45 | null | Palliative (P) | 2017-11-20 | 2017-11-27 | Chlorambucil | N | N | 240033179 | CHLORAMBUCIL |
| 240011943 | 240008128 | 1.8 | 82.3 | null | 2017-07-20 | 2017-08-04 | Chlorambucil | N | null | 240033190 | CHLORAMBUCIL |
| 240011944 | 240008128 | 1.7 | 76.2 | Not known (9) | 2015-05-02 | 2015-05-07 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 240033190 | CYCLOPHOSPHAMIDE |
| 240011945 | 240008130 | 1.91 | 70 | Curative (C) | 2016-12-16 | 2016-12-16 | Cisplatin + Topotecan | N | N | 240033214 | LEAM |
| 240011946 | 240008130 | 1.64 | 97.7 | Disease modification (D) | 2018-02-20 | 2018-03-29 | R IVAC | N | N | 240033214 | METHOTREXATE |